Bruker Corp (BRKR)
60.50
+1.56
(+2.66%)
USD |
NASDAQ |
Nov 07, 16:00
60.50
0.00 (0.00%)
After-Hours: 20:00
Bruker Revenue (TTM): 3.241B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.241B |
| June 30, 2024 | 3.120B |
| March 31, 2024 | 3.001B |
| December 31, 2023 | 2.964B |
| September 30, 2023 | 2.818B |
| June 30, 2023 | 2.714B |
| March 31, 2023 | 2.621B |
| December 31, 2022 | 2.531B |
| September 30, 2022 | 2.506B |
| June 30, 2022 | 2.476B |
| March 31, 2022 | 2.458B |
| December 31, 2021 | 2.418B |
| September 30, 2021 | 2.362B |
| June 30, 2021 | 2.264B |
| March 31, 2021 | 2.118B |
| December 31, 2020 | 1.988B |
| September 30, 2020 | 1.960B |
| June 30, 2020 | 1.970B |
| March 31, 2020 | 2.035B |
| December 31, 2019 | 2.073B |
| September 30, 2019 | 2.026B |
| June 30, 2019 | 1.972B |
| March 31, 2019 | 1.925B |
| December 31, 2018 | 1.896B |
| September 30, 2018 | 1.872B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.842B |
| March 31, 2018 | 1.813B |
| December 31, 2017 | 1.766B |
| September 30, 2017 | 1.706B |
| June 30, 2017 | 1.664B |
| March 31, 2017 | 1.621B |
| December 31, 2016 | 1.611B |
| September 30, 2016 | 1.619B |
| June 30, 2016 | 1.621B |
| March 31, 2016 | 1.646B |
| December 31, 2015 | 1.624B |
| September 30, 2015 | 1.654B |
| June 30, 2015 | 1.677B |
| March 31, 2015 | 1.739B |
| December 31, 2014 | 1.809B |
| September 30, 2014 | 1.853B |
| June 30, 2014 | 1.872B |
| March 31, 2014 | 1.870B |
| December 31, 2013 | 1.839B |
| September 30, 2013 | 1.805B |
| June 30, 2013 | 1.813B |
| March 31, 2013 | 1.779B |
| December 31, 2012 | 1.791B |
| September 30, 2012 | 1.749B |
| June 30, 2012 | 1.720B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.960B
Minimum
Sep 2020
3.241B
Maximum
Sep 2024
2.482B
Average
2.467B
Median
Revenue (TTM) Benchmarks
| Bio-Rad Laboratories Inc | 2.580B |
| Azenta Inc | 658.62M |
| Harvard Bioscience Inc | 101.12M |
| Bionano Genomics Inc | 36.58M |
| Akoya Biosciences Inc | 93.22M |